Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
is a nonsteroidal glucocorticoid receptor antagonist
Administration of Cariprazine (30 µg/kg) reduces the striatal uptake of both radioligands to the level of nonspecific binding compared with baseline PET measurements
In each species
while values in BHK cells were 0
Smiles: CC1N=C(N)SC=1C1=CC=NC(NC2C=CC(=CC=2)N2CCOCC2)=N1
Ruxolitinib sulfate - CAS# 1092939-16-6 alog 2 is a nonsteroidal glucocorticoid receptorRuxolitinib sulfate is the first potent, selective JAK1 2 inhibitor to enter the clinic with IC50s of 3. 3 nM 2. 8 nM, and has > 130 fold selectivity for JAK1 2 versus JAK3. Ruxolitinib potently and selectively inhibits JAK2V617F mediated signaling and proliferation, markedly increases apoptosis in a dose dependent manner, and at 64 nM results in a doubling of cells with depolarized mitochondria in Ba F3 cells. Ruxolitinib demonstrates remarkable
US$ 200.50
US$ 183.00
US$ 151.50
US$ 115.50
US$ 100.50